Arrhythmogenic right ventricular cardiomyopathy/Dysplasia (ARVC/D)

American Journal of Medical Genetics, Part C: Seminars in Medical Genetics

Volumn 163, Issue 3, 2013, Pages 185-197

  Iyer, V Ramesh ^a   Chin, Alvin J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Arrhythmogenic right ventricular cardiomyopathy; Desmosome; Ventricular arrhythmias; Ventricular dysplasia

Indexed keywords

AMIODARONE; CADHERIN; DESMOCOLLIN; DESMOGLEIN; DESMOPLAKIN; MEMBRANE PROTEIN; PLAKOGLOBIN; PLAKOPHILIN; RYANODINE RECEPTOR 2; TRANSCRIPTION FACTOR TBX5; TRANSFORMING GROWTH FACTOR BETA3; TRANSMEMBRANE PROTEIN 43; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE;

ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY DYSPLASIA; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CELL DEATH; CELL DEGENERATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ECHOCARDIOGRAPHY; EXERCISE; FAMILY COUNSELING; FAMILY HISTORY; FIRST DEGREE RELATIVE; GENE MUTATION; HEART GRAFT; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE BIOPSY; HEART PALPITATION; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INFLAMMATORY INFILTRATE; INTRACELLULAR SIGNALING; LIFESTYLE MODIFICATION; MORTALITY; MUSCLE CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PALMOPLANTAR KERATODERMA; PATHOGENESIS; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEFECT; SUDDEN DEATH; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION; ANIMAL; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; DESMOSOME; DIFFERENTIAL DIAGNOSIS; DISEASE MODEL; GENETICS; HEART ARRHYTHMIA; HEART VENTRICLE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ARRHYTHMIAS, CARDIAC; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CELL ADHESION MOLECULES; DESMOSOMES; DIAGNOSIS, DIFFERENTIAL; DISEASE MODELS, ANIMAL; HEART VENTRICLES; HUMANS;

EID: 84880700941     PISSN: 15524868     EISSN: 15524876     Source Type: Journal    
DOI: 10.1002/ajmg.c.31368     Document Type: Article

References (88)

1. Ainsworth CD, Skanes AC, Klein GJ, Gula LJ, Yee R, Krahn AD. 2006. Differentiating arrhythmogenic right ventricular cardiomyopathy from right ventricular outflow tract ventricular tachycardia using multilead QRS duration and axis. Heart Rhythm 3:416-423.
2. Asimaki A, Saffitz JE. 2011. The role of endomyocardial biopsy in ARVC: Looking beyond histology in search of new diagnostic markers. J Cardiovasc Electrophysiol 22:111-117.
3. Asimaki A, Syrris P, Wichter T, Matthias P, Saffitz JE, Mckenna WJ. 2007. A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 81:964-973.
4. Asimaki A, Tandri H, Huang H, Halushka MK, Gautam S, Basso C, Thiene G, Tsatsopoulou A, Protonotarios N, Mckenna WJ, Calkins H, Saffitz JE. 2009. A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med 360:1075-1084.
5. Azaouagh A, Churzidse S, Konorza T, Erbel R. 2011. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: A review and update. Clin Res Cardiol 100:383-394.
6. Basso C, Czarnowska E, Della Barbera M, Bauce B, Beffagna G, Wlodarska EK, Pilichou K, Ramondo A, Lorenzon A, Wozniek O, Corrado D, Daliento L, Danieli GA, Valente M, Nava A, Thiene G, Rampazzo A. 2006. Ultrastructural evidence of intercalated disc remodelling in arrhythmogenic right ventricular cardiomyopathy: An electron microscopy investigation on endomyocardial biopsies. Eur Heart J 27:1847-1854.
7. Basso C, Corrado D, Marcus FI, Nava A, Thiene G. 2009. Arrhythmogenic right ventricular cardiomyopathy. Lancet 373:1289-1300.
8. Bauce B, Basso C, Rampazzo A, Beffagna G, Daliento L, Frigo G, Malacrida S, Settimo L, Danieli G, Thiene G, Nava A. 2005. Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. Eur Heart J 26:1666-1675.
9. Beffagna G, Occhi G, Nava A, Vitiello L, Ditadi A, Basso C, Bauce B, Carraro G, Thiene G, Towbin JA, Danieli GA, Rampazzo A. 2005. Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res 65:366-373.
10. Bowles NE, Ni J, Marcus F, Towbin JA. 2002. The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 39:892-895.
11. Bruneau BG, Logan M, Davis N, Levi T, Tabin CJ, Seidman JG, Seidman CE. 1999. Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome. Dev Biol 211:100-108.
12. Bu L, Jiang X, Martin-Puig S, Caron L, Zhu S, Shao Y, Roberts DJ, Huang PL, Domian IJ, Chien KR. 2009. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature 460:113-117.
13. Burke AP, Farb A, Tashko G, Virmani R. 1998. Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: Are they different diseases? Circulation 97:1571-1580.
14. Cai CL, Liang X, Shi Y, Chu PH, Pfaff SL, Chen J, Evans S. 2003. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 5:877-889.
15. Calkins H, Marcus F. 2008. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: An update. Curr Cardiol Rep 10:367-375.
16. Christensen AH, Benn M, Bundgaard H, Tybjaerg-Hansen A, Haunso S, Svendsen JH. 2010. Wide spectrum of desmosomal mutations in Danish patients with arrhythmogenic right ventricular cardiomyopathy. J Med Genet 47:736-744.
17. Coonar AS, Protonotarios N, Tsatsopoulou A, Needham EW, Houlston RS, Cliff S, Otter MI, Murday VA, Mattu RK, Mckenna WJ. 1998. Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to 17q21. Circulation 97:2049-2058.
18. Corrado D, Thiene G. 2006. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: Clinical impact of molecular genetic studies. Circulation 113:1634-1637.
19. Corrado D, Thiene G, Nava A, Rossi L, Pennelli N. 1990. Sudden death in young competitive athletes: Clinicopathologic correlations in 22 cases. Am J Med 89:588-596.
20. Corrado D, Basso C, Thiene G, Mckenna WJ, Davies MJ, Fontaliran F, Nava A, Silvestri F, Blomstrom-Lundqvist C, Wlodarska EK, Fontaine G, Camerini F. 1997. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: A multicenter study. J Am Coll Cardiol 30:1512-1520.
21. Corrado D, Basso C, Thiene G. 2000. Arrhythmogenic right ventricular cardiomyopathy: Diagnosis, prognosis, and treatment. Heart 83:588-595.
22. Corrado D, Leoni L, Link MS, Della Bella P, Gaita F, Curnis A, Salerno JU, Igidbashian D, Raviele A, Disertori M, Zanotto G, Verlato R, Vergara G, Delise P, Turrini P, Basso C, Naccarella F, Maddalena F, Estes NA III, Buja G, Thiene G. 2003. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 108:3084-3091.
23. Corrado D, Basso C, Pilichou K, Thiene G. 2011. Molecular biology and clinical management of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart 97:530-539.
24. Cox MG, Van Der Zwaag PA, Van Der Werf C, Van Der Smagt JJ, Noorman M, Bhuiyan ZA, Wiesfeld AC, Volders PG, Van Langen IM, Atsma DE, Dooijes D, Van Den Wijngaard A, Houweling AC, Jongbloed JD, Jordaens L, Cramer MJ, Doevendans PA, De Bakker JM, Wilde AA, Van Tintelen JP, Hauer RN. 2011. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: Pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study. Circulation 123:2690-2700.
25. Dalal D, Nasir K, Bomma C, Prakasa K, Tandri H, Piccini J, Roguin A, Tichnell C, James C, Russell SD, Judge DP, Abraham T, Spevak PJ, Bluemke DA, Calkins H. 2005. Arrhythmogenic right ventricular dysplasia: A United States experience. Circulation 112:3823-3832.
26. Garcia-Gras E, Lombardi R, Giocondo MJ, Willerson JT, Schneider MD, Khoury DS, Marian AJ. 2006. Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Clin Invest 116:2012-2021.
27. Gerull B, Heuser A, Wichter T, Paul M, Basson CT, Mcdermott DA, Lerman BB, Markowitz SM, Ellinor PT, Macrae CA, Peters S, Grossmann KS, Drenckhahn J, Michely B, Sasse-Klaassen S, Birchmeier W, Dietz R, Breithardt G, Schulze-Bahr E, Thierfelder L. 2004. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 36:1162-1164.
28. Hamilton RM, Fidler L. 2009. Right ventricular cardiomyopathy in the young: An emerging challenge. Heart Rhythm 6:571-575.
29. Harel I, Maezawa Y, Avraham R, Rinon A, Ma HY, Cross JW, Leviatan N, Hegesh J, Roy A, Jacob-Hirsch J, Rechavi G, Carvajal J, Tole S, Kioussi C, Quaggin S, Tzahor E. 2012. Pharyngeal mesoderm regulatory network controls cardiac and head muscle morphogenesis. Proc Natl Acad Sci USA 109:18839-18844.
30. Hatzfeld M. 1999. The armadillo family of structural proteins. Int Rev Cytol 186:179-224.
31. Kaplan SR, Gard JJ, Protonotarios N, Tsatsopoulou A, Spiliopoulou C, Anastasakis A, Squarcioni CP, Mckenna WJ, Thiene G, Basso C, Brousse N, Fontaine G, Saffitz JE. 2004a. Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm 1:3-11.
32. Kaplan SR, Gard JJ, Carvajal-Huerta L, Ruiz-Cabezas JC, Thiene G, Saffitz JE. 2004b. Structural and molecular pathology of the heart in Carvajal syndrome. Cardiovasc Pathol 13:26-32.
33. Kim C, Wong J, Wen J, Wang S, Wang C, Spiering S, Kan NG, Forcales S, Puri PL, Leone TC, Marine JE, Calkins H, Kelly DP, Judge DP, Chen HS. 2013. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature 494:105-110.
34. Kirchhof P, Fabritz L, Zwiener M, Witt H, Schafers M, Zellerhoff S, Paul M, Athai T, Hiller KH, Baba HA, Breithardt G, Ruiz P, Wichter T, Levkau B. 2006. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation 114:1799-1806.
35. Klauke B, Kossmann S, Gaertner A, Brand K, Stork I, Brodehl A, Dieding M, Walhorn V, Anselmetti D, Gerdes D, Bohms B, Schulz U, Zu Knyphausen E, Vorgerd M, Gummert J, Milting H. 2010. De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy. Hum Mol Genet 19:4595-4607.
36. Kuhl A, Melberg A, Meinl E, Nurnberg G, Nurnberg P, Kehrer-Sawatzki H, Jenne DE. 2008. Myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy 7: Corroboration and narrowing of the critical region on 10q22.3. Eur J Hum Genet 16:367-373.
37. Lescroart F, Kelly RG, Le Garrec JF, Nicolas JF, Meilhac SM, Buckingham M. 2010. Clonal analysis reveals common lineage relationships between head muscles and second heart field derivatives in the mouse embryo. Development 137:3269-3279.
38. Litovsky S, Choy M, Park J, Parrish M, Waters B, Nagashima M, Van Praagh R, Van Praag S. 2000. Absent pulmonary valve with tricuspid atresia or severe tricuspid stenosis: Report of three cases and review of the literature. Pediatr Dev Pathol 3:353-366.
39. Lodder EM, Rizzo S. 2012. Mouse models in arrhythmogenic right ventricular cardiomyopathy. Front Physiol 3:221.
40. Lombardi R, Dong J, Rodriguez G, Bell A, Leung TK, Schwartz RJ, Willerson JT, Brugada R, Marian AJ. 2009. Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy. Circ Res 104:1076-1084.
41. Lorenzon A, Beffagna G, Bauce B, De Bortoli M, Li Mura IE, Calore M, Dazzo E, Basso C, Nava A, Thiene G, Rampazzo A. 2013. Desmin mutations and arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol 111:400-405.
42. Marcus FI, Fontaine GH, Guiraudon G, Frank R, Laurenceau JL, Malergue C, Grosgogeat Y. 1982. Right ventricular dysplasia: A report of 24 adult cases. Circulation 65:384-398.
43. Marcus FI, Zareba W, Calkins H, Towbin JA, Basso C, Bluemke DA, Estes NA III, Picard MH, Sanborn D, Thiene G, Wichter T, Cannom D, Wilber DJ, Scheinman M, Duff H, Daubert J, Talajic M, Krahn A, Sweeney M, Garan H, Sakaguchi S, Lerman BB, Kerr C, Kron J, Steinberg JS, Sherrill D, Gear K, Brown M, Severski P, Polonsky S, Mcnitt S. 2009. Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: Results from the North American Multidisciplinary Study. Heart Rhythm 6:984-992.
44. Marcus FI, Mckenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, Calkins H, Corrado D, Cox MG, Daubert JP, Fontaine G, Gear K, Hauer R, Nava A, Picard MH, Protonotarios N, Saffitz JE, Sanborn DM, Steinberg JS, Tandri H, Thiene G, Towbin JA, Tsatsopoulou A, Wichter T, Zareba W. 2010. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed modification of the task force criteria. Eur Heart J 31:806-814.
45. Matolweni LO, Bardien S, Rebello G, Oppon E, Munclinger M, Ramesar R, Watkins H, Mayosi BM. 2006. Arrhythmogenic right ventricular cardiomyopathy type 6 (ARVC6): Support for the locus assignment, narrowing of the critical region and mutation screening of three candidate genes. BMC Med Genet 7:29.
46. McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundqvist C, Fontaine G, Camerini F. 1994. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 71:215-218.
47. McKoy G, Protonotarios N, Crosby A, Tsatsopoulou A, Anastasakis A, Coonar A, Norman M, Baboonian C, Jeffery S, Mckenna WJ. 2000. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 355:2119-2124.
48. Merner ND, Hodgkinson KA, Haywood AF, Connors S, French VM, Drenckhahn JD, Kupprion C, Ramadanova K, Thierfelder L, Mckenna W, Gallagher B, Morris-Larkin L, Bassett AS, Parfrey PS, Young TL. 2008. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am J Hum Genet 82:809-821.
49. Midiri M, Finazzo M, Brancato M, Hoffmann E, Indovina G, Maria MD, Lagalla R. 1997. Arrhythmogenic right ventricular dysplasia: MR features. Eur Radiol 7:307-312.
50. Muthappan P, Calkins H. 2008. Arrhythmogenic right ventricular dysplasia. Prog Cardiovasc Dis 51:31-43.
51. Nasir K, Rutberg J, Tandri H, Berger R, Tomaselli G, Calkins H. 2003a. Utility of SAECG in arrhythmogenic right ventricle dysplasia. Ann Noninvasive Electrocardiol 8:112-120.
52. Nasir K, Tandri H, Rutberg J, Tichnell C, Spevak P, Crossan J, Baughman KL, Kasper EK, Tomaselli GF, Berger R, Calkins H. 2003b. Filtered QRS duration on signal-averaged electrocardiography predicts inducibility of ventricular tachycardia in arrhythmogenic right ventricle dysplasia. Pacing Clin Electrophysiol 26:1955-1960.
53. Nasir K, Bomma C, Tandri H, Roguin A, Dalal D, Prakasa K, Tichnell C, James C, Spevak PJ, Marcus F, Calkins H. 2004. Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: A need to broaden diagnostic criteria. Circulation 110:1527-1534.
54. Nava A, Thiene G, Canciani B, Scognamiglio R, Daliento L, Buja G, Martini B, Stritoni P, Fasoli G. 1988. Familial occurrence of right ventricular dysplasia: A study involving nine families. J Am Coll Cardiol 12:1222-1228.
55. Newfeld EA, Cole RB, Paul MH. 1967. Ebstein's malformation of the tricuspid valve in the neonate. Functional and anatomic pulmonary outflow tract obstruction. Am J Cardiol 19:727-731.
56. Noorman M, Van Der Heyden MA, Van Veen TA, Cox MG, Hauer RN, De Bakker JM, Van Rijen HV. 2009. Cardiac cell-cell junctions in health and disease: Electrical versus mechanical coupling. J Mol Cell Cardiol 47:23-31.
57. O'donnell D, Cox D, Bourke J, Mitchell L, Furniss S. 2003. Clinical and electrophysiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia. Eur Heart J 24:801-810.
58. Otten E, Lekanne Dit Deprez RH, Weiss MM, Van Slegtenhorst M, Joosten M, Van Der Smagt JJ, De Jonge N, Kerstjens-Frederikse WS, Roofthooft MT, Balk AH, Van Den Berg MP, Ruiter JS, Van Tintelen JP. 2010. Recurrent and founder mutations in the Netherlands: Mutation p.K217del in troponin T2, causing dilated cardiomyopathy. Neth Heart J 18:478-485.
59. Pennell D, Casolo G. 1997. Right ventricular arrhythmia: Emergence of magnetic resonance imaging as an investigative tool. Eur Heart J 18:1843-1845.
60. Peters S, Trummel M, Koehler B, Westermann KU. 2007. The value of different electrocardiographic depolarization criteria in the diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Electrocardiol 40:34-37.
61. Piccini JP, Dalal D, Roguin A, Bomma C, Cheng A, Prakasa K, Dong J, Tichnell C, James C, Russell S, Crosson J, Berger RD, Marine JE, Tomaselli G, Calkins H. 2005. Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm 2:1188-1194.
62. Pilichou K, Nava A, Basso C, Beffagna G, Bauce B, Lorenzon A, Frigo G, Vettori A, Valente M, Towbin J, Thiene G, Danieli GA, Rampazzo A. 2006. Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation 113:1171-1179.
63. Postma F, Liu CH, Dietsche C, Khan M, Lee HK, Paul D, Kanold PO. 2011. Electrical synapses formed by connexin36 regulate inhibition- and experience-dependent plasticity. Proc Natl Acad Sci USA 108:13770-13775.
64. Protonotarios N, Tsatsopoulou A, Patsourakos P, Alexopoulos D, Gezerlis P, Simitsis S, Scampardonis G. 1986. Cardiac abnormalities in familial palmoplantar keratosis. Br Heart J 56:321-326.
65. Protonotarios N, Anastasakis A, Antoniades L, Chlouverakis G, Syrris P, Basso C, Asimaki A, Theopistou A, Stefanadis C, Thiene G, Mckenna WJ, Tsatsopoulou A. 2011. Arrhythmogenic right ventricular cardiomyopathy/dysplasia on the basis of the revised diagnostic criteria in affected families with desmosomal mutations. Eur Heart J 32:1097-1104.
66. Quarta G, Syrris P, Ashworth M, Jenkins S, Zuborne Alapi K, Morgan J, Muir A, Pantazis A, Mckenna WJ, Elliott PM. 2012. Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy. Eur Heart J 33:1128-1136.
67. Rampazzo A, Nava A, Miorin M, Fonderico P, Pope B, Tiso N, Livolsi B, Zimbello R, Thiene G, Danieli GA. 1997. ARVD4, a new locus for arrhythmogenic right ventricular cardiomyopathy, maps to chromosome 2 long arm. Genomics 45:259-263.
68. Rampazzo A, Nava A, Malacrida S, Beffagna G, Bauce B, Rossi V, Zimbello R, Simionati B, Basso C, Thiene G, Towbin JA, Danieli GA. 2002. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 71:1200-1206.
69. Ricci C, Longo R, Pagnan L, Dalla Palma L, Pinamonti B, Camerini F, Bussani R, Silvestri F. 1992. Magnetic resonance imaging in right ventricular dysplasia. Am J Cardiol 70:1589-1595.
70. Saffitz JE. 2005. Dependence of electrical coupling on mechanical coupling in cardiac myocytes: Insights gained from cardiomyopathies caused by defects in cell-cell connections. Ann N Y Acad Sci 1047:336-344.
71. Sen-Chowdhry S, Prasad SK, Mckenna WJ. 2005a. Arrhythmogenic right ventricular cardiomyopathy with fibrofatty atrophy, myocardial oedema, and aneurysmal dilation. Heart 91:784.
72. Sen-Chowdhry S, Syrris P, Mckenna WJ. 2005b. Genetics of right ventricular cardiomyopathy. J Cardiovasc Electrophysiol 16:927-935.
73. Sen-Chowdhry S, Syrris P, Mckenna WJ. 2007a. Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 50:1813-1821.
74. Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E, Mckenna WJ. 2007b. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation 115:1710-1720.
75. Severini GM, Krajinovic M, Pinamonti B, Sinagra G, Fioretti P, Brunazzi MC, Falaschi A, Camerini F, Giacca M, Mestroni L. 1996. A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14. Genomics 31:193-200.
76. Simpson MA, Mansour S, Ahnood D, Kalidas K, Patton MA, McKenna WJ, Behr ER, Crosby AH. 2009. Homozygous mutation of desmocollin-2 in arrhythmogenic right ventricular cardiomyopathy with mild palmoplantar keratoderma and woolly hair. Cardiology 2009:28-34.
77. Syrris P, Ward D, Asimaki A, Sen-Chowdhry S, Ebrahim HY, Evans A, Hitomi N, Norman M, Pantazis A, Shaw AL, Elliott PM, Mckenna WJ. 2006. Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy. Circulation 113:356-364.
78. Tandri H, Saranathan M, Rodriguez ER, Martinez C, Bomma C, Nasir K, Rosen B, Lima JA, Calkins H, Bluemke DA. 2005. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 45:98-103.
79. Taylor M, Graw S, Sinagra G, Barnes C, Slavov D, Brun F, Pinamonti B, Salcedo EE, Sauer W, Pyxaras S, Anderson B, Simon B, Bogomolovas J, Labeit S, Granzier H, Mestroni L. 2011. Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes. Circulation 124:876-885.
80. teRiele ASJM, Bhonsale A, Burt JR, Zimmerman SL, Tandri H. 2012. Genotype-specific pattern of LV involvement in ARVD/C. J Am Coll Card Img 5:849-851.
81. Thiene G, Basso C. 2001. Arrhythmogenic right ventricular cardiomyopathy: An update. Cardiovasc Pathol 10:109-117.
82. Tiso N, Stephan DA, Nava A, Bagattin A, Devaney JM, Stanchi F, Larderet G, Brahmbhatt B, Brown K, Bauce B, Muriago M, Basso C, Thiene G, Danieli GA, Rampazzo A. 2001. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 10:189-194.
83. Valente M, Calabrese F, Thiene G, Angelini A, Basso C, Nava A, Rossi L. 1998. In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy. Am J Pathol 152:479-484.
84. Van Der Zwaag PA, Van Rijsingen IA, Asimaki A, Jongbloed JD, Van Veldhuisen DJ, Wiesfeld AC, Cox MG, Van Lochem LT, De Boer RA, Hofstra RM, Christiaans I, Van Spaendonck-Zwarts KY, Lekanne Dit Deprez RH, Judge DP, Calkins H, Suurmeijer AJ, Hauer RN, Saffitz JE, Wilde AA, Van Den Berg MP, Van Tintelen JP. 2012. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: Evidence supporting the concept of arrhythmogenic cardiomyopathy. Eur J Heart Fail 14:1199-1207.
85. Wlodarska EK, Wozniak O, Konka M, Rydlewska-Sadowska W, Biederman A, Hoffman P. 2006. Thromboembolic complications in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Europace 8:596-600.
86. Xu T, Yang Z, Vatta M, Rampazzo A, Beffagna G, Pilichou K, Scherer SE, Saffitz J, Kravitz J, Zareba W, Danieli GA, Lorenzon A, Nava A, Bauce B, Thiene G, Basso C, Calkins H, Gear K, Marcus F, Towbin JA. 2010. Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 55:587-597.
87. Yang Z, Bowles NE, Scherer SE, Taylor MD, Kearney DL, Ge S, Nadvoretskiy VV, Defreitas G, Carabello B, Brandon LI, Godsel LM, Green KJ, Saffitz JE, Li H, Danieli GA, Calkins H, Marcus F, Towbin JA. 2006. Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Res 99:646-655.
88. Zimmer HG. 1994. Some aspects of cardiac heterogeneity. Basic Res Cardiol 89:101-117.